Polymorphisms in genes encoding nonsarcomeric proteins and their role in the pathogenesis of dilated cardiomyopathy

Herz

Volumn 37, Issue 8, 2012, Pages 836-842

  Staab, J ^a   Ruppert, V ^b   Pankuweit, S ^b   Meyer, T ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autoimmunity; CTLA4 receptor; Dilated cardiomyopathy; Genetics; Nonsarcomeric mutations

Indexed keywords

CD28 ANTIGEN; CELL PROTEIN; CYTOSKELETON PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDUCIBLE T CELL COSTIMULATOR; NUCLEAR PROTEIN; SARCOMERIC PROTEIN; UNCLASSIFIED DRUG; CYTOKINE;

ARTICLE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; CTLA4 GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART MUSCLE CELL; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RISK FACTOR; SARCOMERE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; REVIEW;

CARDIOMYOPATHY, DILATED; CYTOKINES; CYTOSKELETAL PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOMERES;

EID: 84878894233     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3698-6     Document Type: Article

References (57)

1. Mestroni L, Krajinovic M, Severini GM et al (1995) Molecular genetics of dilated cardiomyopathies. Eur Heart J 16(Suppl O):5-9
2. Chang AN, Potter JD (2005) Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev 10:225-235
3. Watkins H, Ashrafian H, Redwood C (2011) Inherited cardiomyopathies. N Engl J Med 364:1643-1656
4. Jacoby D, McKenna WJ (2012) Genetics of inherited cardiomyopathy. Eur Heart J 33:296-304
5. Towbin JA, Hejtmancik JF, Brink P et al (1993) X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87:1854-1865
6. Waldmüller S, Erdmann J, Binner P et al (2011) Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail 13:1185-1192
7. Morimoto S (2008) Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77:659-666
8. Kimura A (2011) Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side). Circ J 75:1756-1765
9. Itoh-Satoh M, Hayashi T, Nishi H et al (2002) Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 291:385-393
10. Knöll R, Hoshijima M, Hoffman HM et al (2002) The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111:943-955
11. Herman DS, Lam L, Taylor MR et al (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366:619-628
12. Haghighi K, Kolokathis F, Pater L et al (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111:869-876
13. Schmitt JP, Kamisago M, Asahi M et al (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299:1410-1413
14. Kranias EG, Bers DM (2007) Calcium and cardiomyopathies. Subcell Biochem 45:523-537
15. Bione S, Maestrini E, Rivella S et al (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8:323-327
16. Bonne G, Di Barletta MR, Varnous S et al (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285-288
17. Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715-1724
18. Funakoshi M, Tsuchiya Y, Arahata K (1999) Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 9:108-114
19. Mounkes LC, Burke B, Stewart CL (2001) The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends Cardiovasc Med 11:280-285
20. Nonen S, Okamoto H, Akino M et al (2005) No positive association between adrenergic receptor variants of ?2cDel322-325, ?1Ser49, ?1Arg389 and the risk for heart failure in the Japanese population. Br J Clin Pharmacol 60:414-417
21. Leineweber K, Heusch G (2009) 1- and 2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol 158:61-69
22. Muthumala A, Drenos F, Elliott PM, Humphries SE (2008) Role of ?-adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis. Eur J Heart Fail 10:3-13
23. Iwai C, Akita H, Shiga N et al (2002) Suppressive effect of the Gly389 allele of the ?1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 66:723-728
24. Forleo C, Sorrentino S, Guida P et al (2007) 1- and 2-Adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 8:589-595
25. Du Preez J, Matolweni LO, Greenberg J et al (2008) The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans. Cardiovasc J Afr 19:15-16
26. Paczkowska A, Szperl M, Maek et al (2009) Polymorphisms of the ?1- and ?2-adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy. Kardiol Pol 67:235-241
27. Regitz-Zagrosek V, Hocher B, Bettmann M et al (2006) 2C-Adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy. Eur Heart J 27:454-459
28. Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127-155
29. Huang CH, Vallejo JG, Kollias G, Mann DL (2009) Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 104:228-237
30. Lv H, Havari E, Pinto S et al (2011) Impaired thymic tolerance to ?-myosin directs autoimmunity to the heart in mice and humans. J Clin Invest 121:1561-1573
31. Metzger TC, Anderson MS (2011) Myocarditis: a defect in central immune tolerance? J Clin Invest 121:1251-1253
32. Tang D, Kang R, Coyne CB et al (2012) PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249:158-175
33. Maier R, Krebs P, Ludewig B (2004) Immunopathological basis of virus-induced myocarditis. Clin Dev Immunol 11:1-5
34. Richer MJ, Horwitz MS (2009) The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity. J Innate Immun 1:421-434
35. Mann DL (2011) The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 108:1133-1145
36. Yajima T (2011) Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol 6:551-566
37. Marchant DJ, Boyd JH et al (2012) Inflammation in myocardial diseases. Circ Res 110:126-144
38. Nindl V, Maier R, Ratering D et al (2012) Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur J Immunol 42:2311-2321
39. Li HS, Ligons DL, Rose NR (2008) Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7:168-173
40. Portig I, Sandmoeller A, Kreilinger S, Maisch B (2009) HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 42:33-40
41. Liu W, Li WM, Gao C et al (2005) Relationship of CTLA-4 exon 1 A49G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy (in Chinese) Zhonghua Yi Xue Za Zhi 85:3221-3224
42. Ruppert V, Meyer T, Struwe C et al (2010) Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy. Eur J Hum Genet 18:694-699
43. Kristiansen OP, Larsen ZM, Pociot F (2000) CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1:170-184
44. Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102-115
45. Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511
46. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP (2004) B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21:401-413
47. Tang AL, Teijaro JR, Njau MN et al (2008) CTLA4 expression is an indicator and regulator of steady-state CD4+FoxP3+T cell homeostasis. J Immunol 181:1806-1813
48. Friedline RH, Brown DS, Nguyen H et al (2009) CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 206:421-434
49. Ligers A, Teleshova N, Masterman T et al (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145-152
50. Mäurer M, Loserth S, Kolb-Mäurer A et al (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 54:1-8
51. Anjos S, Nguyen A, Ounissi-Benkalha H et al (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478-46486
52. Tivol EA, Borriello F, Schweitzer AN et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547
53. Waterhouse P, Penninger JM, Timms E et al (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988
54. Chambers CA, Sullivan TJ, Allison JP (1997) Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 7:885-895
55. Khattri R, Auger JA, Griffin MD et al (1999) Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 162:5784-5791
56. Mandelbrot DA, McAdam AJ, Sharpe AH (1999) B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med 189:435-440
57. Butty V, Roy M, Sabeti P et al (2007) Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes. Proc Natl Acad Sci USA 104:570-575